These findings demonstrate that AAV-SPL treatment prevents the development of nephrosis, Stat3 activation, and proinflammatory and fibrogenic cytokine upregulation in various tissues of Sgpl1-KO mice. This evidence concerns the gene SGPL1 and nephrosis.